Form D · Other Technology
TAXON BIOSCIENCES INC.
Tiburon, CA · CIK 0001575382
Offering snapshot reported May 6, 2013 · SEC filing
- Reported sold
- $4.01M Offering amount: $9.18M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 22, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 6, 2013 | Initial | $4,011,526 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-196007
Total Amount Sold includes the conversion of debt and other consideration
Source: Form D, filed May 6, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Ashby | Director, Executive |
| Molly Ashby | Director |
| Paul Deutch | Director |
| James Kim | Director |
| Meghan Sharp | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3150 Paradise Drive Bldg. 30
Tiburon, CA, 94920
Tiburon, CA, 94920